Table 2.
Proportional distribution of HIV subtypes in adults initiating and reinitiating ART in Uruguay, 2018–2019.
| Subtype | All (N = 205) |
With Integrase Resistance-Associated Mutation G163KR (N = 26) |
||
|---|---|---|---|---|
| n | % | n | % | |
| HIV-1 subtype B | 86 | 42.0 | 0 | 0.0 |
| Recombinant of F1, B | 52 | 25.4 | 9 | 34.6 |
| HIV-1 subtype F1 | 17 | 8.3 | 9 | 34.6 |
| Recombinant of 12_BF, B | 13 | 6.3 | 3 | 11.5 |
| HIV-1 subtype C | 9 | 4.4 | 0 | 0.0 |
| HIV-1 CRF 12_BF | 6 | 2.9 | 3 | 11.5 |
| Recombinant of B, A1 | 5 | 2.4 | 0 | 0.0 |
| Recombinant of C, B | 3 | 1.5 | 0 | 0.0 |
| HIV-1 CRF 31_BC | 3 | 1.5 | 0 | 0.0 |
| Recombinant of 12_BF, A1 | 2 | 1.0 | 2 | 7.7 |
| HIV-1 CRF 47_BF | 2 | 1.0 | 0 | 0.0 |
| HIV-1 CRF 20_BG | 1 | 0.5 | 0 | 0.0 |
| Recombinant of 31_BC, C | 1 | 0.5 | 0 | 0.0 |
| Recombinant of 42_BF, F1 | 1 | 0.5 | 0 | 0.0 |
| Recombinant of B, 39_BF | 1 | 0.5 | 0 | 0.0 |
| Recombinant of B, 47_BF | 1 | 0.5 | 0 | 0.0 |
| Recombinant of B, C | 1 | 0.5 | 0 | 0.0 |
| HIV-1 CRF 42_BF | 1 | 0.5 | 0 | 0.0 |
Unweighted proportions of HIV-1 subtypes assigned using the REGA HIV-1 subtyping tool (v3.46).